Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-093-4 | CAS number: 176969-34-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 27 - 30 Jul 2009
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- The study followed the standard guideline of reference (OECD 429), which describes a procedure designed to evaluate this endpoint, but with an important protocol deviation. Cellular proliferation was not determined by incorporated radioactivity, thus no disintegrations per minute (DPM). Instead, lymph node cell count was used as direct measurement of cell proliferation and a lower cut-off value of 1.4 times increase of stimulation index was used. The results were reviewed for reliability and assessed as valid, and the study was conducted under GLP condition.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- adopted in 2002
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- adopted in 2010
- Deviations:
- yes
- Remarks:
- Proliferation assessed on Day 4 instead Day 6 by lymph node cell count instead of incorporated radioactivity and the analysis was not part of the GLP study, no Draize scoring, pos. control was run in an independent experiment
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Version / remarks:
- adopted in 2003
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Nederland, AD Horst, The Netherlands
- Females (if applicable) nulliparous and non-pregnant: yes
- Microbiological status of animals, when known: SPF
- Age at study initiation: 8 weeks
- Weight at study initiation: 24 - 30 g
- Housing: During the acclimatisation period up to 8 mice were housed together in conventional Makrolon type III cages. During the study period the animals were housed individually in type II cages. Low-dust wood shaving was used as bedding (Lignocel BK 8-15, Rettenmaier & Söhne GmbH & Co, Rosenberg, Germany)
- Diet: Provimi Kliba SA 3883 (Provimi Kliba SA, Kaiseraugst, Switzerland), ad libitum
- Water: tap water, ad libitum
- Acclimation period: at least 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2
- Humidity (%): 40 - 70
- Air changes (per hr): about 10
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- dimethylformamide
- Concentration:
- 3, 10 and 30% (w/w)
- No. of animals per dose:
- 6 animals
- Details on study design:
- MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Lymph node weight, cell count, ear swelling and ear weight were determined for the control and treatment animals.
- Criteria used to consider a positive response: Stimulation Index of 1.4 for the cell count and increase of 2 x 10E-2 mm for ear swelling (about 10% of the control values).
TREATMENT PREPARATION AND ADMINISTRATION:
25 µL of the test item formulation were applied epicutaneously onto the dorsal part of both ears of the animals. The treatment was repeated on three consecutive days. One day after the last application (study Day 4) the animals were sacrificed and the lymphatic organs (auricular lymph nodes) were isolated. Lymph nodes were weighed and the cell counts were determined. In addition, ear thickness was determined prior to the first treatment and before sacrifice. The thickness of both auricles of the animals was measured using a spring-loaded micrometer. At study termination, the ear weights of the sacrificed animals were measured using an 8 mm ear punch of each ear. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- When it was statistically reasonable, the values from treated groups were compared with those from the vehicle control group by a one-way analysis of variance (ANOVA) when the variances are considered homogeneous according to a homogeneity testing like Cochran's test. Alternatively, if the variances are considered to be heterogenous (p<0.05), a nonparametric Kruskal-Wallis test has been used (Kruskal-Wallis ANOVA) at significance levels of 5%. Two sided multiple test procedures were done according to Dunnett or Bonferroni-Holm, respectively. Outlying values in the LN weights were eliminated at a probability level of 99% by Nalimov's method. In addition, for the LLNA/IMDS the smallest significant differences in the means were calculated by Scheffe's method, which according to Sachs can be used for both equal and unequal sample sizes. In this method of statistical processing of measurements a large number of comparisons is made, and as a result of the multiple tests the overall probability of error is considerably greater than the p values suggest (increased number of false-positive results). On the other hand, the known methods of adjusting p values lead to an excessive increase in the number of false negatives. In view of these problems the biological and lexicological relevance is also taken into consideration in the evaluation of statistical significance. For this reason, in the case of indices only the standard deviations between groups and difference analysis of the mean values were used in the evaluation of the biological relevance.
Results and discussion
- Positive control results:
- The test methodology was checked for reliability in a test on female NMRI mice using alpha hexyl cinnamic aldehyde formulated in different vehicles (PEG 400, DAE 433, DMF, MEK, acetone/olive oil (4:1) and Cremophor EL/ physiological saline solution 2% v/v) at concentrations of 3%, 10% and 30%. The results for the positive control were valid, but not included in the study report of the present study.
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 1
- Test group / Remarks:
- vehicle control
- Remarks on result:
- other: SI = Cell count of treated group / Cell count of control group
- Key result
- Parameter:
- SI
- Value:
- 0.96
- Test group / Remarks:
- 3% formulation
- Remarks on result:
- other: SI = Cell count of treated group / Cell count of control group
- Key result
- Parameter:
- SI
- Value:
- 0.69
- Test group / Remarks:
- 10% formulation
- Remarks on result:
- other: SI = Cell count of treated group / Cell count of control group
- Key result
- Parameter:
- SI
- Value:
- 0.66
- Test group / Remarks:
- 30% formulation
- Remarks on result:
- other: SI = Cell count of treated group / Cell count of control group
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA
There was no increase in the stimulation indices for cell counts or for weights of the draining lymph nodes after application of the test item. The "positive level" which is 1.4 for the cell count index was never reached or exceeded in any dose group. The "positive level" of ear swelling, which is 2 x 10E-2 mm increase, i.e. about 10% of the control values, has not been reached or exceeded in any dose group. No substance specific effects were determined for ear weights either.
CLINICAL OBSERVATIONS:
No clinical signs of toxicity were reported for any animal.
BODY WEIGHTS
Body weights of the animals were not affected by any treatment.
Any other information on results incl. tables
Table 1: Direct LLNA
Dose (%) | Weight index ± SD (mean ± SD in %) | Cell count index ± SD (mean ± SD in %) |
DMF | 1.00 ± 12.60 | 1.00 ± 14.88 |
3 | 1.00 ± 28.76 | 0.96 ± 38.62 |
10 | 0.84 ± 21.02 | 0.69 ± 30.15 |
30 | 0.95 ± 24.94 | 0.66 ± 29.73 |
DMF: Dimethylformamide, vehicle control |
Table 2: Ear swelling
Dose (%) | Day 1 (mean ± SD in %) | Day 4 (mean ± SD in %) | Index Day 4 |
DMF | 17.33 ± 2.84 | 17.58 ± 2.93 | 1.00 |
3 | 17.58 ± 3.80 | 18.00 ± 3.35 | 1.02 |
10 | 17.75 ± 2.55 | 17.92 ± 2.87 | 1.02 |
30 | 17.58 ± 2.93 | 17.75 ± 2.55 | 1.01 |
DMF: Dimethylformamide, vehicle control |
Table 3: Ear weight
Dose (%) | Day 4 (mean ± SD in %) | Index Day 4 |
DMF | 11.91 ± 5.07 | 1.00 |
3 | 11.64 ± 6.56 | 0.98 |
10 | 11.98 ± 4.82 | 1.01 |
30 | 11.84 ± 4.33 | 0.99 |
DMF: Dimethylformamide, vehicle control |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The substance was tested for skin sensitisation in the LLNA test with mice according to OECD guideline 429. No skin sensitisation could be evidenced.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)
Mimo że ECHA udostępnia wiele materiałów online w Twoim języku, część tej strony jest dostępna tylko w języku angielskim. Więcej o praktykach ECHA związanych z mwielojęzycznością.
Witamy na stronie internetowej ECHA. Strona ta nie jest w pełni obsługiwana przez Internet Explorer 7 (i wcześniejsze wersje). Prosimy o zainstalowanie nowszej wersji Internet Explorer.
Niniejsza strona używa plików cookies, aby zapewnić optymalne korzystanie z naszych stron internetowych.
Dodatkowe informacje: jak używamy plików cookies.